1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Brain Cancer Targeted Drug Market Size (2020-2031) 2.1.2 Brain Cancer Targeted Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) 2.1.3 World Current & Future Analysis for Brain Cancer Targeted Drug by Country/Region (2020, 2024 & 2031) 2.2 Brain Cancer Targeted Drug Segment by Type 2.2.1 Belzutifan (Welireg) 2.2.2 Bevacizumab (Avastin) 2.2.3 Everolimus (Afinitor) 2.3 Brain Cancer Targeted Drug Market Size by Type 2.3.1 Brain Cancer Targeted Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) 2.3.2 Global Brain Cancer Targeted Drug Market Size Market Share by Type (2020-2025) 2.4 Brain Cancer Targeted Drug Segment by Application 2.4.1 Hospital 2.4.2 Retail Pharmacy 2.4.3 Other 2.5 Brain Cancer Targeted Drug Market Size by Application 2.5.1 Brain Cancer Targeted Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) 2.5.2 Global Brain Cancer Targeted Drug Market Size Market Share by Application (2020-2025) 3 Brain Cancer Targeted Drug Market Size by Player 3.1 Brain Cancer Targeted Drug Market Size Market Share by Player 3.1.1 Global Brain Cancer Targeted Drug Revenue by Player (2020-2025) 3.1.2 Global Brain Cancer Targeted Drug Revenue Market Share by Player (2020-2025) 3.2 Global Brain Cancer Targeted Drug Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Brain Cancer Targeted Drug by Region 4.1 Brain Cancer Targeted Drug Market Size by Region (2020-2025) 4.2 Global Brain Cancer Targeted Drug Annual Revenue by Country/Region (2020-2025) 4.3 Americas Brain Cancer Targeted Drug Market Size Growth (2020-2025) 4.4 APAC Brain Cancer Targeted Drug Market Size Growth (2020-2025) 4.5 Europe Brain Cancer Targeted Drug Market Size Growth (2020-2025) 4.6 Middle East & Africa Brain Cancer Targeted Drug Market Size Growth (2020-2025) 5 Americas 5.1 Americas Brain Cancer Targeted Drug Market Size by Country (2020-2025) 5.2 Americas Brain Cancer Targeted Drug Market Size by Type (2020-2025) 5.3 Americas Brain Cancer Targeted Drug Market Size by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Brain Cancer Targeted Drug Market Size by Region (2020-2025) 6.2 APAC Brain Cancer Targeted Drug Market Size by Type (2020-2025) 6.3 APAC Brain Cancer Targeted Drug Market Size by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Brain Cancer Targeted Drug Market Size by Country (2020-2025) 7.2 Europe Brain Cancer Targeted Drug Market Size by Type (2020-2025) 7.3 Europe Brain Cancer Targeted Drug Market Size by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Brain Cancer Targeted Drug by Region (2020-2025) 8.2 Middle East & Africa Brain Cancer Targeted Drug Market Size by Type (2020-2025) 8.3 Middle East & Africa Brain Cancer Targeted Drug Market Size by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Brain Cancer Targeted Drug Market Forecast 10.1 Global Brain Cancer Targeted Drug Forecast by Region (2026-2031) 10.1.1 Global Brain Cancer Targeted Drug Forecast by Region (2026-2031) 10.1.2 Americas Brain Cancer Targeted Drug Forecast 10.1.3 APAC Brain Cancer Targeted Drug Forecast 10.1.4 Europe Brain Cancer Targeted Drug Forecast 10.1.5 Middle East & Africa Brain Cancer Targeted Drug Forecast 10.2 Americas Brain Cancer Targeted Drug Forecast by Country (2026-2031) 10.2.1 United States Market Brain Cancer Targeted Drug Forecast 10.2.2 Canada Market Brain Cancer Targeted Drug Forecast 10.2.3 Mexico Market Brain Cancer Targeted Drug Forecast 10.2.4 Brazil Market Brain Cancer Targeted Drug Forecast 10.3 APAC Brain Cancer Targeted Drug Forecast by Region (2026-2031) 10.3.1 China Brain Cancer Targeted Drug Market Forecast 10.3.2 Japan Market Brain Cancer Targeted Drug Forecast 10.3.3 Korea Market Brain Cancer Targeted Drug Forecast 10.3.4 Southeast Asia Market Brain Cancer Targeted Drug Forecast 10.3.5 India Market Brain Cancer Targeted Drug Forecast 10.3.6 Australia Market Brain Cancer Targeted Drug Forecast 10.4 Europe Brain Cancer Targeted Drug Forecast by Country (2026-2031) 10.4.1 Germany Market Brain Cancer Targeted Drug Forecast 10.4.2 France Market Brain Cancer Targeted Drug Forecast 10.4.3 UK Market Brain Cancer Targeted Drug Forecast 10.4.4 Italy Market Brain Cancer Targeted Drug Forecast 10.4.5 Russia Market Brain Cancer Targeted Drug Forecast 10.5 Middle East & Africa Brain Cancer Targeted Drug Forecast by Region (2026-2031) 10.5.1 Egypt Market Brain Cancer Targeted Drug Forecast 10.5.2 South Africa Market Brain Cancer Targeted Drug Forecast 10.5.3 Israel Market Brain Cancer Targeted Drug Forecast 10.5.4 Turkey Market Brain Cancer Targeted Drug Forecast 10.6 Global Brain Cancer Targeted Drug Forecast by Type (2026-2031) 10.7 Global Brain Cancer Targeted Drug Forecast by Application (2026-2031) 10.7.1 GCC Countries Market Brain Cancer Targeted Drug Forecast 11 Key Players Analysis 11.1 Merck & Co. 11.1.1 Merck & Co. Company Information 11.1.2 Merck & Co. Brain Cancer Targeted Drug Product Offered 11.1.3 Merck & Co. Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025) 11.1.4 Merck & Co. Main Business Overview 11.1.5 Merck & Co. Latest Developments 11.2 Roche 11.2.1 Roche Company Information 11.2.2 Roche Brain Cancer Targeted Drug Product Offered 11.2.3 Roche Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025) 11.2.4 Roche Main Business Overview 11.2.5 Roche Latest Developments 11.3 Novartis 11.3.1 Novartis Company Information 11.3.2 Novartis Brain Cancer Targeted Drug Product Offered 11.3.3 Novartis Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025) 11.3.4 Novartis Main Business Overview 11.3.5 Novartis Latest Developments 12 Research Findings and Conclusion
List of Tables Table 1. Brain Cancer Targeted Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions) Table 2. Brain Cancer Targeted Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Belzutifan (Welireg) Table 4. Major Players of Bevacizumab (Avastin) Table 5. Major Players of Everolimus (Afinitor) Table 6. Brain Cancer Targeted Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions) Table 7. Global Brain Cancer Targeted Drug Market Size by Type (2020-2025) & ($ millions) Table 8. Global Brain Cancer Targeted Drug Market Size Market Share by Type (2020-2025) Table 9. Brain Cancer Targeted Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions) Table 10. Global Brain Cancer Targeted Drug Market Size by Application (2020-2025) & ($ millions) Table 11. Global Brain Cancer Targeted Drug Market Size Market Share by Application (2020-2025) Table 12. Global Brain Cancer Targeted Drug Revenue by Player (2020-2025) & ($ millions) Table 13. Global Brain Cancer Targeted Drug Revenue Market Share by Player (2020-2025) Table 14. Brain Cancer Targeted Drug Key Players Head office and Products Offered Table 15. Brain Cancer Targeted Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Brain Cancer Targeted Drug Market Size by Region (2020-2025) & ($ millions) Table 19. Global Brain Cancer Targeted Drug Market Size Market Share by Region (2020-2025) Table 20. Global Brain Cancer Targeted Drug Revenue by Country/Region (2020-2025) & ($ millions) Table 21. Global Brain Cancer Targeted Drug Revenue Market Share by Country/Region (2020-2025) Table 22. Americas Brain Cancer Targeted Drug Market Size by Country (2020-2025) & ($ millions) Table 23. Americas Brain Cancer Targeted Drug Market Size Market Share by Country (2020-2025) Table 24. Americas Brain Cancer Targeted Drug Market Size by Type (2020-2025) & ($ millions) Table 25. Americas Brain Cancer Targeted Drug Market Size Market Share by Type (2020-2025) Table 26. Americas Brain Cancer Targeted Drug Market Size by Application (2020-2025) & ($ millions) Table 27. Americas Brain Cancer Targeted Drug Market Size Market Share by Application (2020-2025) Table 28. APAC Brain Cancer Targeted Drug Market Size by Region (2020-2025) & ($ millions) Table 29. APAC Brain Cancer Targeted Drug Market Size Market Share by Region (2020-2025) Table 30. APAC Brain Cancer Targeted Drug Market Size by Type (2020-2025) & ($ millions) Table 31. APAC Brain Cancer Targeted Drug Market Size by Application (2020-2025) & ($ millions) Table 32. Europe Brain Cancer Targeted Drug Market Size by Country (2020-2025) & ($ millions) Table 33. Europe Brain Cancer Targeted Drug Market Size Market Share by Country (2020-2025) Table 34. Europe Brain Cancer Targeted Drug Market Size by Type (2020-2025) & ($ millions) Table 35. Europe Brain Cancer Targeted Drug Market Size by Application (2020-2025) & ($ millions) Table 36. Middle East & Africa Brain Cancer Targeted Drug Market Size by Region (2020-2025) & ($ millions) Table 37. Middle East & Africa Brain Cancer Targeted Drug Market Size by Type (2020-2025) & ($ millions) Table 38. Middle East & Africa Brain Cancer Targeted Drug Market Size by Application (2020-2025) & ($ millions) Table 39. Key Market Drivers & Growth Opportunities of Brain Cancer Targeted Drug Table 40. Key Market Challenges & Risks of Brain Cancer Targeted Drug Table 41. Key Industry Trends of Brain Cancer Targeted Drug Table 42. Global Brain Cancer Targeted Drug Market Size Forecast by Region (2026-2031) & ($ millions) Table 43. Global Brain Cancer Targeted Drug Market Size Market Share Forecast by Region (2026-2031) Table 44. Global Brain Cancer Targeted Drug Market Size Forecast by Type (2026-2031) & ($ millions) Table 45. Global Brain Cancer Targeted Drug Market Size Forecast by Application (2026-2031) & ($ millions) Table 46. Merck & Co. Details, Company Type, Brain Cancer Targeted Drug Area Served and Its Competitors Table 47. Merck & Co. Brain Cancer Targeted Drug Product Offered Table 48. Merck & Co. Brain Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 49. Merck & Co. Main Business Table 50. Merck & Co. Latest Developments Table 51. Roche Details, Company Type, Brain Cancer Targeted Drug Area Served and Its Competitors Table 52. Roche Brain Cancer Targeted Drug Product Offered Table 53. Roche Brain Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 54. Roche Main Business Table 55. Roche Latest Developments Table 56. Novartis Details, Company Type, Brain Cancer Targeted Drug Area Served and Its Competitors Table 57. Novartis Brain Cancer Targeted Drug Product Offered Table 58. Novartis Brain Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 59. Novartis Main Business Table 60. Novartis Latest Developments List of Figures Figure 1. Brain Cancer Targeted Drug Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Brain Cancer Targeted Drug Market Size Growth Rate (2020-2031) ($ millions) Figure 6. Brain Cancer Targeted Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 7. Brain Cancer Targeted Drug Sales Market Share by Country/Region (2024) Figure 8. Brain Cancer Targeted Drug Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 9. Global Brain Cancer Targeted Drug Market Size Market Share by Type in 2024 Figure 10. Brain Cancer Targeted Drug in Hospital Figure 11. Global Brain Cancer Targeted Drug Market: Hospital (2020-2025) & ($ millions) Figure 12. Brain Cancer Targeted Drug in Retail Pharmacy Figure 13. Global Brain Cancer Targeted Drug Market: Retail Pharmacy (2020-2025) & ($ millions) Figure 14. Brain Cancer Targeted Drug in Other Figure 15. Global Brain Cancer Targeted Drug Market: Other (2020-2025) & ($ millions) Figure 16. Global Brain Cancer Targeted Drug Market Size Market Share by Application in 2024 Figure 17. Global Brain Cancer Targeted Drug Revenue Market Share by Player in 2024 Figure 18. Global Brain Cancer Targeted Drug Market Size Market Share by Region (2020-2025) Figure 19. Americas Brain Cancer Targeted Drug Market Size 2020-2025 ($ millions) Figure 20. APAC Brain Cancer Targeted Drug Market Size 2020-2025 ($ millions) Figure 21. Europe Brain Cancer Targeted Drug Market Size 2020-2025 ($ millions) Figure 22. Middle East & Africa Brain Cancer Targeted Drug Market Size 2020-2025 ($ millions) Figure 23. Americas Brain Cancer Targeted Drug Value Market Share by Country in 2024 Figure 24. United States Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 25. Canada Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 26. Mexico Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 27. Brazil Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 28. APAC Brain Cancer Targeted Drug Market Size Market Share by Region in 2024 Figure 29. APAC Brain Cancer Targeted Drug Market Size Market Share by Type (2020-2025) Figure 30. APAC Brain Cancer Targeted Drug Market Size Market Share by Application (2020-2025) Figure 31. China Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 32. Japan Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 33. South Korea Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 34. Southeast Asia Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 35. India Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 36. Australia Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 37. Europe Brain Cancer Targeted Drug Market Size Market Share by Country in 2024 Figure 38. Europe Brain Cancer Targeted Drug Market Size Market Share by Type (2020-2025) Figure 39. Europe Brain Cancer Targeted Drug Market Size Market Share by Application (2020-2025) Figure 40. Germany Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 41. France Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 42. UK Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 43. Italy Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 44. Russia Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 45. Middle East & Africa Brain Cancer Targeted Drug Market Size Market Share by Region (2020-2025) Figure 46. Middle East & Africa Brain Cancer Targeted Drug Market Size Market Share by Type (2020-2025) Figure 47. Middle East & Africa Brain Cancer Targeted Drug Market Size Market Share by Application (2020-2025) Figure 48. Egypt Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 49. South Africa Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 50. Israel Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 51. Turkey Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 52. GCC Countries Brain Cancer Targeted Drug Market Size Growth 2020-2025 ($ millions) Figure 53. Americas Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 54. APAC Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 55. Europe Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 56. Middle East & Africa Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 57. United States Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 58. Canada Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 59. Mexico Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 60. Brazil Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 61. China Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 62. Japan Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 63. Korea Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 64. Southeast Asia Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 65. India Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 66. Australia Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 67. Germany Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 68. France Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 69. UK Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 70. Italy Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 71. Russia Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 72. Egypt Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 73. South Africa Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 74. Israel Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 75. Turkey Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions) Figure 76. Global Brain Cancer Targeted Drug Market Size Market Share Forecast by Type (2026-2031) Figure 77. Global Brain Cancer Targeted Drug Market Size Market Share Forecast by Application (2026-2031) Figure 78. GCC Countries Brain Cancer Targeted Drug Market Size 2026-2031 ($ millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck & Co.|||Roche|||Novartis